Developer docs
API playgroundTry for free, no card

Search company profiles

Institute for Health Policy

Full company profile

uuid002v38h

Namestring
Institute for Health Policy
Legal namestring
Institute for Health Policy
Websiteurl
ihp.lk
Company typeenum
Private
Founded yearstring
-
Descriptiontext

The Institute for Health Policy (IHP) is an independent, non-partisan research institution headquartered at 72 Park Street, Colombo 02, Sri Lanka, operating as a regional centre of excellence for health policy research. Its core programs are research studies and data platforms rather than commercial products: the Sri Lanka Health and Ageing Study (SLHAS), a nationally representative longitudinal cohort of 6,665 adults across all districts; Sri Lanka Health Accounts (SLHA), regular health-expenditure tracking using WHO-endorsed System of Health Accounts methodology since 1990; SLOTS, a daily public opinion polling platform with MRP-capable analysis; the Linked Immunisation Action Network, a Gavi-supported peer-learning network for middle-income countries; and the Diagnose-DR Pilot Study evaluating AI-assisted retinal imaging for diabetic retinopathy screening in collaboration with University College London and the University of Colombo.

IHP serves government ministries of health (Sri Lanka, Bangladesh), multilateral and bilateral development organisations (Gavi, UNICEF, World Bank, WHO), academic partners (Johns Hopkins, UCL, University of Colombo, University of Peradeniya), and private foundations (Velux Stiftung, Swiss National Science Foundation / Swiss Agency for Development and Cooperation). It does not sell commercial products; all research, training, and technical-assistance activities are funded through grants, sponsorships, and institutional partnerships, and findings are disseminated via publications, conferences, study tours, and a website at ihp.lk. Go-to-market is relationship-led and partnership-driven, with the institution embedded in regional health-policy networks and functioning as a technical-assistance intermediary between international funders and South/Southeast Asian ministries of health.

Short descriptiontext

The Institute for Health Policy is an independent, non-profit research institution in Colombo, Sri Lanka, conducting longitudinal health studies (SLHAS), health expenditure tracking (SLHA), public opinion polling (SLOTS), and AI-assisted diabetic retinopathy screening, serving government health ministries, multilateral agencies (Gavi, UNICEF, World Bank), and academic partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersColombo, Sri Lanka
HQ citystring
Colombo
HQ countrystring
Sri Lanka
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health policy research, public health analytics, longitudinal ageing studies, health expenditure tracking, immunisation network facilitation
Industry4 codes
PRIMARYHLAJAMAA
Public Health Strategy, Policy & Legislation
SECONDARYHLAJALAO
International & Global Public Health Aid Administration (Government Donors)
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program Administration
SECONDARYBPAIAJAB
Public Health Policy, Planning & Governance
SECONDARYEDAHAGAM
Global Health Institutes & Programs
Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities
NAICS code2 codes
  • Research and Development in the Social Sciences and Humanities54172
  • Administration of Public Health Programs92312
SIC code1 code
  • Services-Health Services8000
Product category
Health Policy Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Grants and Sponsorships
TypeSubscription Recurring
Description

IHP conducts research in partnerships and with sponsors to fund its operations. Funding sources include international organizations, government agencies, and development partners such as Gavi, UNICEF, World Bank, and private foundations.

ihp.lk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Institute for Health Policy is an independent research institution that conducts health policy research, longitudinal studies, public opinion polling, and capacity-building programs in Sri Lanka and the wider South Asia-Pacific region. Its portfolio spans health expenditure tracking, population ageing studies, immunisation programming, and AI-assisted screening research, delivered through government, multilateral, and academic partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • SLHAS tracks 6,665 adults across all Sri Lankan districts for longitudinal health and ageing research
+1 more record
Product overview1 text field

The Institute for Health Policy is an independent research institution that operates as a portfolio of research studies and platforms rather than a unified software product. The core offerings include: SLHAS (Sri Lanka Health and Ageing Study) - a longitudinal health research study; SLHA (Sri Lanka Health Accounts) - health expenditure tracking and analytics; SLOTS - a daily public opinion polling platform; and the Survey of Co-operative and Private Hospitals - a sector statistics collection initiative. Additional programs include the Linked Immunisation Action Network (a Gavi-supported collaborative learning network for middle-income countries) and the Diagnose-DR initiative (AI-assisted diabetic retinopathy screening research). The institution focuses on health policy research, analysis, and training to improve health and social systems in Sri Lanka and the wider region.

Product and service6 records
1Sri Lanka Health and Ageing Study (SLHAS)
CategoryHealth Research Study
Description

Longitudinal nationally representative research study tracking 6,665 adults across every district of Sri Lanka, linking health with wider determinants and public policies to monitor ageing and changes in older-adult health.

2Sri Lanka Health Accounts (SLHA)
CategoryHealth Expenditure Analytics
Description

Regular tracking and reporting of health expenditure flows in Sri Lanka using a Health Accounts Framework based on the WHO-endorsed System of Health Accounts (OECD SHA) methodology, covering 1990-2019.

3SLOTS - Survey of Topical Issues
CategoryPublic Opinion Polling Platform
Description

Daily polling of a high-quality, nationally representative panel of people in Sri Lanka to survey topical issues, offering rapid turnaround and Multilevel Regression and Poststratification (MRP) for analysis. Ongoing since September 2021.

4Survey of Co-operative and Private Hospitals in Sri Lanka
CategoryHealth Sector Statistics Survey
Description

Annual survey that improves the availability of statistics on the contribution of co-operative and private hospitals to Sri Lanka's health services.

5Linked Immunisation Action Network
6Diagnose Diabetic Retinopathy (Diagnose-DR) Pilot Study
CategoryAI-Assisted Screening Research
Description

Multi-centre project studying the feasibility of AI-assisted retinal imaging cameras used by non-specialist healthcare staff to screen people with diabetes for diabetic retinopathy in Sri Lanka.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research partnership for the Johns Hopkins/IHP Exemplar study examining the response of Sri Lanka's health system to the COVID-19 pandemic. A full-day workshop was held on 4 April 2023 to present and discuss findings.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Gavi supports the Linked Immunisation Action Network (Linked), a collaborative learning network for middle-income countries. IHP serves as regional partner for South Asia-Pacific region and leads on electronic immunisation registries (EIR).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

R4D facilitates and manages the Linked Immunisation Action Network with IHP as regional partner for South Asia-Pacific. R4D provides logistical support for network activities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regional partner for Europe-Central Asia and leads on new vaccine introduction within the Linked Immunisation Action Network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaborator on the Diagnose-DR project studying AI-assisted retinal imaging for diabetic retinopathy screening in Sri Lanka.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Supported a study tour coordinated by IHP for Bangladesh Ministry of Health and Family Welfare officials to learn from Sri Lanka's primary healthcare system (December 2024).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborating institution within the SLHAS research consortium, presenting findings at the SLHAS 1st Conference.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic collaborator within the SLHAS research consortium, involved in parallel session presentations on Diabetes, Food and Nutrition, and Quality of Life research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic partner hosting the Eye Care Center for Diagnose-DR Pilot Study and collaborating on SLHAS research. Deans and lecturers from Medical Faculty attended SLHAS conference.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International organization representative attending SLHAS 1st Conference. WHO endorses the System of Health Accounts (SHA) methodology used in Sri Lanka Health Accounts.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International organization representative attending SLHAS 1st Conference and involved in immunisation programme workshops through Linked Network.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Institute for Health Policy

Health Policy Researchihp.lk

The Institute for Health Policy is an independent, non-profit research institution in Colombo, Sri Lanka, conducting longitudinal health studies (SLHAS), health expenditure tracking (SLHA), public opinion polling (SLOTS), and AI-assisted diabetic retinopathy screening, serving government health ministries, multilateral agencies (Gavi, UNICEF, World Bank), and academic partners.

What Institute for Health Policy does

The Institute for Health Policy (IHP) is an independent, non-partisan research institution headquartered at 72 Park Street, Colombo 02, Sri Lanka, operating as a regional centre of excellence for health policy research. Its core programs are research studies and data platforms rather than commercial products: the Sri Lanka Health and Ageing Study (SLHAS), a nationally representative longitudinal cohort of 6,665 adults across all districts; Sri Lanka Health Accounts (SLHA), regular health-expenditure tracking using WHO-endorsed System of Health Accounts methodology since 1990; SLOTS, a daily public opinion polling platform with MRP-capable analysis; the Linked Immunisation Action Network, a Gavi-supported peer-learning network for middle-income countries; and the Diagnose-DR Pilot Study evaluating AI-assisted retinal imaging for diabetic retinopathy screening in collaboration with University College London and the University of Colombo.

IHP serves government ministries of health (Sri Lanka, Bangladesh), multilateral and bilateral development organisations (Gavi, UNICEF, World Bank, WHO), academic partners (Johns Hopkins, UCL, University of Colombo, University of Peradeniya), and private foundations (Velux Stiftung, Swiss National Science Foundation / Swiss Agency for Development and Cooperation). It does not sell commercial products; all research, training, and technical-assistance activities are funded through grants, sponsorships, and institutional partnerships, and findings are disseminated via publications, conferences, study tours, and a website at ihp.lk. Go-to-market is relationship-led and partnership-driven, with the institution embedded in regional health-policy networks and functioning as a technical-assistance intermediary between international funders and South/Southeast Asian ministries of health.

Institute for Health Policy firmographics

Firmographics
Name
Institute for Health Policy
Legal name
Institute for Health Policy
Website
https://ihp.lk
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
The Institute for Health Policy is an independent, non-profit research institution in Colombo, Sri Lanka, conducting longitudinal health studies (SLHAS), health expenditure tracking (SLHA), public opinion polling (SLOTS), and AI-assisted diabetic retinopathy screening, serving government health ministries, multilateral agencies (Gavi, UNICEF, World Bank), and academic partners.
Ownership category
akta.pro rank

Institute for Health Policy industry classification

Industry
Product category
Health Policy Research
NAICS
Research and Development in the Social Sciences and Humanities (54172), Administration of Public Health Programs (92312)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAJAMAA
Public Health Strategy, Policy & Legislation
SECONDARYHLAJALAO
International & Global Public Health Aid Administration (Government Donors)
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program Administration
SECONDARYBPAIAJAB
Public Health Policy, Planning & Governance
SECONDARYEDAHAGAM
Global Health Institutes & Programs
Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

  • Health policy research
  • Public health analytics
  • Longitudinal ageing studies
  • Health expenditure tracking
  • Immunisation network facilitation

Where Institute for Health Policy is headquartered

Location

Headquarters

HQ city
Colombo
HQ country
Sri Lanka
HQ region
Asia

Offices1 record

Markets served

Institute for Health Policy business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Revenue model

  1. Research Grants and Sponsorships: IHP conducts research in partnerships and with sponsors to fund its operations. Funding sources include international organizations, government agencies, and development partners such as Gavi, UNICEF, World Bank, and private foundations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Institute for Health Policy product offering

Product offering

Core offering

The Institute for Health Policy is an independent research institution that conducts health policy research, longitudinal studies, public opinion polling, and capacity-building programs in Sri Lanka and the wider South Asia-Pacific region. Its portfolio spans health expenditure tracking, population ageing studies, immunisation programming, and AI-assisted screening research, delivered through government, multilateral, and academic partnerships.

Product overview

The Institute for Health Policy is an independent research institution that operates as a portfolio of research studies and platforms rather than a unified software product. The core offerings include: SLHAS (Sri Lanka Health and Ageing Study) - a longitudinal health research study; SLHA (Sri Lanka Health Accounts) - health expenditure tracking and analytics; SLOTS - a daily public opinion polling platform; and the Survey of Co-operative and Private Hospitals - a sector statistics collection initiative. Additional programs include the Linked Immunisation Action Network (a Gavi-supported collaborative learning network for middle-income countries) and the Diagnose-DR initiative (AI-assisted diabetic retinopathy screening research). The institution focuses on health policy research, analysis, and training to improve health and social systems in Sri Lanka and the wider region.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sri Lanka Health and Ageing Study (SLHAS) Longitudinal nationally representative research study tracking 6,665 adults across every district of Sri Lanka, linking health with wider determinants and public policies to monitor ageing and changes in older-adult health.
  • Sri Lanka Health Accounts (SLHA) Regular tracking and reporting of health expenditure flows in Sri Lanka using a Health Accounts Framework based on the WHO-endorsed System of Health Accounts (OECD SHA) methodology, covering 1990-2019.
  • SLOTS - Survey of Topical Issues Daily polling of a high-quality, nationally representative panel of people in Sri Lanka to survey topical issues, offering rapid turnaround and Multilevel Regression and Poststratification (MRP) for analysis. Ongoing since September 2021.
  • Survey of Co-operative and Private Hospitals in Sri Lanka Annual survey that improves the availability of statistics on the contribution of co-operative and private hospitals to Sri Lanka's health services.
  • Linked Immunisation Action Network
  • Diagnose Diabetic Retinopathy (Diagnose-DR) Pilot Study Multi-centre project studying the feasibility of AI-assisted retinal imaging cameras used by non-specialist healthcare staff to screen people with diabetes for diabetic retinopathy in Sri Lanka.

Quantifiable outcome

  • SLHAS tracks 6,665 adults across all Sri Lankan districts for longitudinal health and ageing research
  • +1 more outcomes

Companies that use Institute for Health Policy

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Institute for Health Policy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Institute for Health Policy partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerCollaborative research partnership for the Johns Hopkins/IHP Exemplar study examining the response of Sri Lanka's health system to the COVID-19 pandemic. A full-day workshop was held on 4 April 2023 to present and discuss findings.
  • Gavi, the Vaccine AlliancecoreStrategic or Co-development PartnerGavi supports the Linked Immunisation Action Network (Linked), a collaborative learning network for middle-income countries. IHP serves as regional partner for South Asia-Pacific region and leads on electronic immunisation registries (EIR).
  • Results for Development (R4D)coreStrategic or Co-development PartnerR4D facilitates and manages the Linked Immunisation Action Network with IHP as regional partner for South Asia-Pacific. R4D provides logistical support for network activities.
  • Curatio International FoundationcoreStrategic or Co-development PartnerRegional partner for Europe-Central Asia and leads on new vaccine introduction within the Linked Immunisation Action Network.
  • University College London (UCL)coreStrategic or Co-development PartnerResearch collaborator on the Diagnose-DR project studying AI-assisted retinal imaging for diabetic retinopathy screening in Sri Lanka.
  • UNICEF BangladeshminorStrategic or Co-development PartnerSupported a study tour coordinated by IHP for Bangladesh Ministry of Health and Family Welfare officials to learn from Sri Lanka's primary healthcare system (December 2024).
  • Medical Research InstituteminorStrategic or Co-development PartnerCollaborating institution within the SLHAS research consortium, presenting findings at the SLHAS 1st Conference.
  • University of PeradeniyaminorStrategic or Co-development PartnerAcademic collaborator within the SLHAS research consortium, involved in parallel session presentations on Diabetes, Food and Nutrition, and Quality of Life research.
  • University of ColombocoreStrategic or Co-development PartnerKey academic partner hosting the Eye Care Center for Diagnose-DR Pilot Study and collaborating on SLHAS research. Deans and lecturers from Medical Faculty attended SLHAS conference.
  • World Health Organization (WHO)minorStrategic or Co-development PartnerInternational organization representative attending SLHAS 1st Conference. WHO endorses the System of Health Accounts (SHA) methodology used in Sri Lanka Health Accounts.
  • World BankminorStrategic or Co-development PartnerInternational organization representative attending SLHAS 1st Conference and involved in immunisation programme workshops through Linked Network.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Institute for Health Policy competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Institute for Health Policy social profiles

Digital presence

Institute for Health Policy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Institute for Health Policy leadership team

Management profile

Number of profiles

Profiles4 records

Institute for Health Policy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Institute for Health Policy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Health Policy

What does Institute for Health Policy do?

The Institute for Health Policy is an independent research institution that conducts health policy research, longitudinal studies, public opinion polling, and capacity-building programs in Sri Lanka and the wider South Asia-Pacific region. Its portfolio spans health expenditure tracking, population ageing studies, immunisation programming, and AI-assisted screening research, delivered through government, multilateral, and academic partnerships.

Is Institute for Health Policy a public or private company?

Institute for Health Policy is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Institute for Health Policy founded?

Institute for Health Policy was founded in -1. It employs 11 to 50 people.

Where is Institute for Health Policy based?

Institute for Health Policy is headquartered in Colombo, Sri Lanka, in the Asia region.

How does Institute for Health Policy make money?

One revenue line is on record: research Grants and Sponsorships.

Does Institute for Health Policy have an API?

No public API is recorded for Institute for Health Policy.

What industry is Institute for Health Policy in?

Institute for Health Policy's product category is Health Policy Research. Its primary akta.pro industry code is HLAJAMAA, Public Health Strategy, Policy & Legislation, with a secondary code of HLAJALAO, International & Global Public Health Aid Administration (Government Donors). Its NAICS code is 54172 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales